STOCK TITAN

Sonnet BioTherapeutics Holdings, Inc. (SONN) Net Income by Year

SONN

Sonnet BioTherapeutics Holdings, Inc. reported a net loss of $16.0M in fiscal year 2025. This represents a decrease of 115.3% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Sonnet BioTherapeutics Holdings, Inc. has filed alongside them.

FY2025 annual
Net Income -$16.0M
YoY -115.3%
Source SEC Filings (10-K/10-Q) Latest period FY2025, ended Sep 30, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

SONN Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-K
Net Income-$16.0M-115.3%-$7.4M+60.5%-$18.8MN/A-$25.0M-3.0%-$24.3M-36.9%-$17.7M-158.6%-$6.9M-0.9%-$6.8M+25.1%-$9.1M+25.2%-$12.1M-89.5%-$6.4M-22.8%-$5.2M-64.7%-$3.2M-172.3%-$1.2M

SONN Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-QQ2'2310-QQ1'2310-Q
Net IncomeN/A-$3.8M-7.7%-$3.5M-1055.4%-$3.2M-170.5%N/A-$3.5M+11.2%$365K+106.4%-$1.2M+78.9%-$3.7M-$3.9M+49.9%-$5.7M+31.0%-$5.5M+10.6%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Sonnet BioTherapeutics Holdings, Inc. financials

Frequently Asked Questions

What was Sonnet BioTherapeutics Holdings, Inc.'s net income in fiscal year 2025?

Sonnet BioTherapeutics Holdings, Inc. reported a net loss of $16.0M in fiscal year 2025.

How fast is Sonnet BioTherapeutics Holdings, Inc.'s net income growing?

Sonnet BioTherapeutics Holdings, Inc. (SONN) net income fell by 115.3% year over year, from -$7.4M to -$16.0M in fiscal year 2025.

How has Sonnet BioTherapeutics Holdings, Inc.'s net income changed over the years?

Across the 15 fiscal years this page covers, Sonnet BioTherapeutics Holdings, Inc. (SONN) net income went from -$1.2M in fiscal year 2011 to -$16.0M in fiscal year 2025.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Sonnet BioTherapeutics Holdings, Inc. (SONN) reported on that line in every period on record.